Drug Product Filled with Berkshire Sterile’s Low Loss Fill Process Receives FDA Green Light
Globe Newswire RNAimmune, a biotech company focused on developing groundbreaking mRNA therapies, recently received FDA approval to begin Phase 1 clinical studies for an investigational new drug (IND). The drug…